The big questions in Luigi Mangione case as he returns to court

Luigi Mangione is set to appear in a New York state court in February 2025, with his murder trial commencing in less than a month. This case has already garnered national attention and is anticipated to become an even larger public spectacle.

Mangione is scheduled to return to court on Tuesday for a hearing, which is expected to draw his supporters, many of whom view him as a symbol of resistance against US healthcare costs. These supporters are likely to queue for hours to gain entry. The case has generated extensive online discussion from both critics and backers, with many analyzing Mangione's intentions and even his appearance. The fervor is expected to intensify on September 8, when jury selection begins.

Prosecutors allege that Mangione shot and killed Brian Thompson, a UnitedHealthcare executive and father of two, in Midtown Manhattan in 2024. Mangione could face decades in prison. He has pleaded not guilty to all charges, including second-degree murder and weapons-related offenses.

While much of what is expected at the state trial—including the prosecution's case, Mangione's defense, and the obstacles both parties face—has been previewed in months of court filings and arguments, some questions remain. On Tuesday, a judge may establish additional ground rules for the trial and other aspects of the case.

A crucial element of the Mangione case was decided earlier this summer, following a multi-day hearing in December where the judge determined which evidence prosecutors could present during the trial. Mangione's legal team aggressively sought to exclude evidence recovered during his arrest in Pennsylvania, alleging that state police improperly seized and searched his possessions and failed to properly advise him of his constitutional rights before questioning.

The defense successfully excluded some items found in Mangione's backpack: a gun magazine, cell phone, passport, wallet, and computer chip. However, Judge Gregory Carro allowed a gun and a notebook containing Mangione's purported writings to be admitted at trial, which are considered vital to the prosecution.

Prosecutors have presented surveillance footage showing Thompson being shot from behind by a hooded individual. They also used footage to reconstruct Mangione's alleged movements after the shooting, along with ballistics and fingerprint evidence that they claim strengthens their case.

As the trial approaches, Mangione's team has not yet revealed its full strategy. So far, his lawyers have not offered a robust alternative theory to the one presented by prosecutors. Mitchell Epner, a former federal prosecutor, remarked, "We do not have, like in 'The Fugitive,' the idea of the one-armed man who's the real killer," referencing a 1993 thriller about a man wrongly convicted of his wife's murder.

Earlier this summer, Mangione's lawyers proposed, then quickly withdrew, an "extreme emotional disturbance" argument. Under New York law, this defense requires lawyers to demonstrate that a defendant "acted under the influence of extreme emotional disturbance for which there was a reasonable explanation or excuse." Such a defense could allow the jury to consider the less severe charge of manslaughter instead of second-degree murder, but jurors would need to be convinced of the accused's state of mind at the time.

Some experts have wondered if Mangione would pursue a full insanity plea, which differs from emotional disturbance, but his lawyers have not proposed it. Cheryl Bader, who leads the Criminal Defense Clinic at Fordham University School of Law, stated, "Short of being delusional, or having no understanding of the nature of what one is doing, an insanity defense is not likely to be successful." Mangione's team did not immediately respond to a request for comment.

As in every US criminal trial, the prosecution bears the burden of proving its case to the jury beyond a reasonable doubt, a high legal standard. Epner noted, "The more his case is about the question of who killed the victim, the easier it is for the prosecution." He suggested that other themes, such as healthcare in America, could be potential narrative threads that might sway a jury in Mangione's favor. "The more it's about the other peripheral issues, the harder it is for the prosecution," he added.

This question, which must be resolved before the trial, could determine whether the proceedings become a massive spectacle across traditional media, social media, and streaming platforms. In recent weeks, Mangione's lawyers have questioned procedures for admitting journalists into court and why an overflow room for additional spectators had not been arranged. The defense also requested that the trial be "broadcast live," although New York state courts do not permit public live streams.

In a letter to Judge Carro, prosecutors stated they have "no role in developing" media procedures at trial and "will have no role in selecting which news reporters attend the trial." In a new filing on Monday night, the Manhattan district attorney's office indicated it would "defer to the court's judgement" on courtroom access. However, the DA cautioned that adequate security was necessary to prevent spectators from covertly recording the trial from an overflow room, which would violate New York law.

While the public can be admitted to court in New York, space is often limited at high-profile trials. According to spokesman Al Baker, the court and its communications office were "actively finalising the plan for the upcoming trial, including arrangement for an overflow room." He affirmed, "We remain firmly committed to providing the greatest possible access for both the media and the public," adding that the court is "evaluating the complex logistical and safety considerations involved."